Hookipa Biotech AG
Hookipa Biotech AG, headquartered in Austria, is a pioneering company in the biotechnology sector, specialising in innovative immunotherapies for cancer treatment. Founded in 2011, Hookipa has made significant strides in the development of its proprietary platform, which harnesses the power of viral vectors to stimulate robust immune responses against tumours. With a focus on advancing its lead product candidates, Hookipa's unique approach combines cutting-edge science with a commitment to improving patient outcomes. The company has established a strong market position, recognised for its groundbreaking research and development efforts in the field of oncolytic immunotherapy. As it continues to expand its operational reach, Hookipa Biotech AG remains dedicated to transforming cancer care through its novel therapeutic solutions.
DitchCarbon Score
How does Hookipa Biotech AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Hookipa Biotech AG's score of 21 is higher than 86% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Hookipa Biotech AG's reported carbon emissions
Hookipa Biotech AG, headquartered in Austria (AT), currently does not have publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the company may still be engaged in sustainability initiatives typical of the biotech industry, focusing on reducing environmental impact through innovative practices. As the industry increasingly prioritises climate action, Hookipa Biotech AG may align with broader trends in reducing greenhouse gas emissions and enhancing sustainability. Further information on their climate strategies would be beneficial to understand their commitments in this area.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Hookipa Biotech AG is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
